Skip to main content

Future Prospects for Diagnostic Test Accuracy Studies in Dementia

  • Chapter
Diagnostic Test Accuracy Studies in Dementia
  • 1047 Accesses

Abstract

This chapter examines some possible future prospects for diagnostic test accuracy studies in dementia, in terms of both potential problems and opportunities. A proposal for the role of pragmatic diagnostic test accuracy studies concludes these considerations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abernethy Holland AJ, Larner AJ. Central nervous system/brain tumour 2-week referral guidelines: prospective 3-year audit. Clin Oncol. 2008;20:201–2.

    Article  CAS  Google Scholar 

  • Aji BM, Larner AJ. Screening for dementia: is one simple question the answer? Clin Med. 2015;15:111–2.

    Google Scholar 

  • Alzheimer’s Society. Mapping the Dementia Gap: Study produced by Tesco, Alzheimer’s Society and Alzheimer’s Scotland. London: Alzheimer’s Society; 2011.

    Google Scholar 

  • Alzheimer’s Society. Mapping the Dementia Gap 2012. Progress on improving diagnosis of dementia 2011-2012. London: Alzheimer’s Society; 2013.

    Google Scholar 

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition, text revision (DSM-IV-TR). Washington: American Psychiatric Association; 2000.

    Google Scholar 

  • Amieva H, Jacqmin-Gadda H, Orgogozo JM, et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain. 2005;128:1093–101.

    Article  PubMed  Google Scholar 

  • Arevalo-Rodriguez I, Segura O, Sola I, Bonfill X, Sanchez E, Alonso-Coello P. Diagnostic tools for Alzheimer’s disease dementia and other dementias: an overview of diagnostic test accuracy (DTA) systematic reviews. BMC Neurol. 2014;14(1):183.

    Google Scholar 

  • Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367:795–804 [Erratum N Engl J Med. 2012;367:780].

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bonello M, Larner AJ. Is the applause sign useful for diagnosis of dementia and MCI? J Neurol Neurosurg Psychiatry. 2015;86:abstract accepted.

    Google Scholar 

  • Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49:7–18.

    Article  CAS  PubMed  Google Scholar 

  • Brunet M. Targets for dementia diagnoses will lead to overdiagnosis. BMJ. 2014;348:g2224.

    Article  PubMed  Google Scholar 

  • Brunet MD, McCartney H, Heath I, et al. There is no evidence base for proposed dementia screening. BMJ. 2012;345:e8588.

    Article  PubMed  Google Scholar 

  • Burch J, Marson A, Beyer F, et al. Dilemmas in the interpretation of diagnostic accuracy studies on presurgical workup for epilepsy surgery. Epilepsia. 2012;53:1294–302.

    Article  PubMed  Google Scholar 

  • Cagliarini AM, Price HL, Livemore ST, Larner AJ. Will use of the Six-Item Cognitive Impairment Test help to close the dementia diagnosis gap? Aging Health. 2013;9:563–6.

    Article  CAS  Google Scholar 

  • Carnero-Pardo C, Espejo-Martinez B, Lopez-Alcalde S, et al. Diagnostic accuracy, effectiveness and cost for cognitive impairment and dementia screening of three short cognitive tests applicable to illiterates. PLoS One. 2011;6(11):e27069.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Department of Health. Prime Minister’s Challenge on Dementia. Delivering major improvements in dementia care and research by 2015. London: Department of Health; 2012a.

    Google Scholar 

  • Department of Health. Using the Commissioning for Quality and Innovation (CQUIN) payment framework. Guidance on the new national goals 2012–13. London: Department of Health; 2012b.

    Google Scholar 

  • Doran M, Larner AJ. NICE/SCIE dementia guidance: time to reconsider. Adv Clin Neurosci Rehabil. 2008;8(1):34–5.

    Google Scholar 

  • Dudas RB, Berrios GE, Hodges JR. The Addenbrooke’s Cognitive Examination (ACE) in the differential diagnosis of early dementias versus affective disorder. Am J Geriatr Psychiatry. 2005;13:218–26.

    Article  PubMed  Google Scholar 

  • Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, Bossuyt PM, Deeks JJ. Assessing the value of diagnostic tests: a framework for designing and evaluating trials. BMJ. 2012;344:e686.

    Article  PubMed  Google Scholar 

  • Fox C, Lafortune L, Boustani M, Dening T, Rait G, Brayne C. Screening for dementia – is it a no brainer? Int J Clin Pract. 2013;67:1076–80.

    Article  CAS  PubMed  Google Scholar 

  • Ghadiri-Sani M, Larner AJ. Head turning sign for diagnosis of dementia and mild cognitive impairment: a revalidation. J Neurol Neurosurg Psychiatry. 2013;84:e2.

    Google Scholar 

  • Hancock P, Larner AJ. Clinical utility of Patient Health Questionnaire-9 (PHQ-9) in memory clinics. Int J Psychiatry Clin Pract. 2009;13:188–91.

    Article  CAS  PubMed  Google Scholar 

  • Hancock P, Larner AJ. Cornell Scale for Depression in Dementia (CSDD): clinical utility in a memory clinic. Int J Psychiatry 2015;19:71–4.

    Google Scholar 

  • Hort J, Bartos A, Pirttila T, Scheltens P. Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe. Eur J Neurol. 2010;17:90–6.

    Article  CAS  PubMed  Google Scholar 

  • Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383:911–22.

    Article  PubMed Central  PubMed  Google Scholar 

  • Jack Jr CR, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207–16.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Johnson KA, Sperling RA, Gidicsin CM et al. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer’s disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement. 2013;9(5Suppl):S72–83.

    Google Scholar 

  • Julayanont P, Phillips N, Chertkow H, Nasreddine ZS. Montreal Cognitive Assessment (MoCA): concept and clinical review. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. London: Springer; 2013. p. 111–51.

    Chapter  Google Scholar 

  • Knapp M, King D, Romeo R, et al. Cost effectiveness of a manual based coping strategy programme in promoting the mental health of family carers of people with dementia (the START (STrAtegies for RelaTives) study): a pragmatic randomised controlled trial. BMJ. 2013;347:f6342.

    Article  PubMed Central  PubMed  Google Scholar 

  • Kotagal V, Langa KM, Plassman BL, et al. Factors associated with cognitive evaluations in the United States. Neurology. 2015;84:64–71.

    Article  PubMed  Google Scholar 

  • Larner AJ. A dictionary of neurological signs. Clinical neurosemiology. Dordrecht: Kluwer; 2001.

    Google Scholar 

  • Larner AJ. Head turning sign: pragmatic utility in clinical diagnosis of cognitive impairment. J Neurol Neurosurg Psychiatry. 2012a;83:852–3.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Mini-Mental Parkinson (MMP) as a dementia screening test: comparison with the Mini-Mental State Examination (MMSE). Curr Aging Sci. 2012b;5:136–9.

    Article  PubMed  Google Scholar 

  • Larner AJ. Screening utility of the “attended alone” sign for subjective memory impairment. Alzheimer Dis Assoc Disord. 2014a;28:364–5.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Neurological signs of possible diagnostic value in the cognitive disorders clinic. Pract Neurol. 2014b;14:332–5.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Dementia in clinical practice: a neurological perspective. Pragmatic studies in the cognitive function clinic (2nd edition). London: Springer; 2014c.

    Book  Google Scholar 

  • Lincoln P, Fenton K, Alessi C, et al. The Blackfriars Consensus on brain health and dementia. Lancet. 2014;383:1805–6.

    Article  PubMed  Google Scholar 

  • Mahieux F, Michelet D, Manifacier M-J, Boller F, Fermanian J, Guillard A. Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson’s disease. Behav Neurol. 1995;8:15–22.

    Article  CAS  PubMed  Google Scholar 

  • Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet. 2005;365:2007–12.

    Article  CAS  PubMed  Google Scholar 

  • Mattsson N, Zetterberg H, Hansson O et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302:385–93.

    Google Scholar 

  • McAlister FA, Straus SE. Sackett DL, on behalf of the CARE-COAD1 Group: why we need large, simple studies of the clinical examination: the problem and a proposed solution. Lancet. 1999;354:1721–4.

    Article  CAS  PubMed  Google Scholar 

  • Moyer VA; US Preventive Services Task Force. Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:791–7.

    Google Scholar 

  • Musso M, Cohen AS, Auster TL, McGovern JE. Investigation of the Montreal Cognitive Assessment (MoCA) as a cognitive screener in severe mental illness. Psychiatr Res. 2014;220:664–8.

    Article  Google Scholar 

  • Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.

    Article  PubMed  Google Scholar 

  • National Institute for Clinical Excellence. Principles for best practice in clinical audit. Abingdon: Radcliffe Medical Press; 2002.

    Google Scholar 

  • National Institute for Health and Clinical Excellence/Social Care Institute for Excellence. Dementia: supporting people with dementia and their carers in health and social care. NICE Clinical Guidance 42. London: National Institute for Health and Clinical Excellence (www.nice.org.uk/cG042), 2006.

  • Noel-Storr AH, McCleery JM, Richard E, et al. Reporting standards for studies of diagnostic test accuracy in dementia: the STARDdem Initiative. Neurology. 2014;83:364–73.

    Article  PubMed Central  PubMed  Google Scholar 

  • Orrell M, Aguirre E, Spector A, et al. Maintenance cognitive stimulation therapy for dementia: single-blind, multicentre, pragmatic randomised controlled trial. Br J Psychiatry. 2014;204:454–61.

    Article  PubMed  Google Scholar 

  • Panicker J, Larner AJ. Two-week wait referrals for CNS cancer – are they working? J Neurol Neurosurg Psychiatry. 2012;83 Suppl 2:A30–1.

    Article  Google Scholar 

  • Panza F, Solfizzi V, Imbimbo BP, Logroscino G. Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return? Expert Opin Biol Ther. 2014;14:1465–76.

    Article  CAS  PubMed  Google Scholar 

  • Prestia A, Caroli A, Herholz K, et al. Diagnostic accuracy of markers for prodromal Alzheimer’s disease in independent clinical series. Alzheimers Dement. 2013;9:677–86.

    Article  PubMed Central  PubMed  Google Scholar 

  • Rosser Matthews J. Quantification and the quest for medical certainty. Princeton: Princeton University Press; 1995.

    Google Scholar 

  • Rotomskis A, Margeviciute R, Germanavicius A, et al. Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke’s Cognitive Examination-Revised. 2015;submitted.

    Google Scholar 

  • Sackett DL, Haynes RB. The architecture of diagnostic research. In: Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002. p. 19–38.

    Google Scholar 

  • Snyder PJ, Kahle-Wrobleski K, Brannan S, et al. Assessing cognition and function in Alzheimer’s disease clinical trials: do we have the right tools? Alzheimers Dement. 2014;10:853–60.

    Article  PubMed  Google Scholar 

  • Swainson R, Hodges JR, Galton CJ, et al. Early detection and differential diagnosis of Alzheimer’s disease and depression with neuropsychological tests. Dement Geriatr Cogn Disord. 2001;12:265–80.

    Article  CAS  PubMed  Google Scholar 

  • Villeda SA, Plambeck KE, Middeldorp J, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med. 2014;20:659–63.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wilson JMG, Jungner G. Principles and practice of screening for disease. Public health paper No. 34. Geneva: World Health Organization; 1968.

    Google Scholar 

  • Wimo A, Religa D, Spangberg K, Edlund AK, Winblad B, Eriksdotter M. Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry. Int J Geriatr Psychiatry. 2013;28:1039–44.

    Article  PubMed  Google Scholar 

  • Wimo A, Ballard C, Brayne C, et al. Health economic evaluation of treatments for Alzheimer’s disease: impact of new diagnostic criteria. J Intern Med. 2014;275:304–16.

    Article  CAS  PubMed  Google Scholar 

  • Wolfsgruber S, Jessen F, Wiese B, et al. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy. Am J Geriatr Psychiatry. 2014;22:1017–28.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Larner, A.J. (2015). Future Prospects for Diagnostic Test Accuracy Studies in Dementia. In: Diagnostic Test Accuracy Studies in Dementia. Springer, Cham. https://doi.org/10.1007/978-3-319-16697-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16697-1_6

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-16696-4

  • Online ISBN: 978-3-319-16697-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics